caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1659356640

Anca BulgaruMD

Hematology-OncologyNorwich, CTI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Anca Bulgaru's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 52 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
THE WILLIAM W BACKUS HOSPITAL39713,009
DALAL, AJAY119719
Dennis Slater
Hematology-Oncology · Norwich, CT
1092,417
Justin Routhier
Diagnostic Radiology · Boston, MA
75493
Jane Genido-Trujillo
Nurse Practitioner · Waterford, CT
50823
Allison Weeks
Nurse Practitioner · Norwich, CT
481,334
Quest Diagnostics Llc
Clinical Laboratory · Wallingford, CT
42285
Herb Lustberg
Diagnostic Radiology · Norwich, CT
42389
HARTFORD HEALTHCARE AT HOME, INC36249
POWELL, STEVEN33238
Mirela Stancu
Pathology · Providence, RI
33290
John Foley
Cardiology · Norwich, CT
30159
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
800
Unique beneficiaries
—
Total services
1,350
Distinct HCPCS
13
Medicare payment
$86K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 119 Hematology-Oncology providers in CT — top quintile (cohort median 735).
PRESCRIBING · PART D · 2024
Total Rx claims
1,514
Beneficiaries
—
Total drug cost
$1.8M
Distinct drugs
35
Brand share
27.1%
Top prescribed drugs
Anastrozole411 claims
Tamoxifen Citrate138 claims
Apixaban131 claims
Gabapentin98 claims
Palbociclib65 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
86.5
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.